SIMI ROY: Open Payments
NPI 1790298008 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $522 |
| Teva Pharmaceuticals USA, Inc. | 4 | $295 |
| Janssen Pharmaceuticals, Inc | 4 | $237 |
| ABBVIE INC. | 3 | $73 |
| Alkermes, Inc. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: INGREZZA, UZEDY, INVEGA SUSTENNA, VRAYLAR, COBENFY, VIVITROL, ARISTADA, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
